EndoGlyph Diff Lab proprietary watches
M664 · EndoGlyph LLC
← All offers

M664 · Controlled-substance API

DEA APQ × API Production Watch

A proprietary Diff Lab watch for controlled-substance API producers — DEA aggregate production quota (APQ) versus API production / government YERS on one DIFF clock.

What you get

Recurring alerts when APQ context and production / YERS signals disagree — so you don’t schedule API campaigns against a quota clock that just moved, or miss a window when YERS says otherwise.

  • Watch scoped to your substance / establishment context
  • APQ × API production / gov YERS DIFF
  • Weekly digest of quota-path vs production-clock mismatches

One APQ miss against a live production schedule dwarfs a year of seats.

Meter

Seat
$799–1,499 / mo
Your substance / establishment scope
Custom setup
$3,000–5,000 setup
Plus monthly seat

This is not

  • A DEA form-filling or quota-application service
  • Pharma ERP or MES software
  • Generic “controlled substances compliance” suite

Diff Lab sells the APQ × API production / YERS DIFF — not a DEA filing desk.

Who it’s for

  • Controlled-substance API producers watching DEA APQ against production / YERS clocks
  • Ops / regulatory desks that already read APQ notices but need a production mismatch alert
  • Anyone burned by scheduling a campaign against a quota print that YERS never confirmed

FAQ

What does APQ × YERS mean here?

DEA aggregate production quota context joined to API production and government YERS signals. Diff Lab scores disagreement — it does not file DEA forms or resell portals.

Is this legal or DEA advice?

No. It is a proprietary derived watch for operational awareness. Not legal, DEA, or FDA advice.

How does checkout work?

Stripe checkout below (Payment Link wired at go-live). Mid-band seat is $999/mo. Email collected at checkout receives the weekly digest.

Start a seat

$999 / mo · mid-band seat · DEA APQ × API Production

Subscribe — $999/mo seat

Stripe checkout · email collected for weekly digest

EndoGlyph Diff Lab · EndoGlyph LLC. Proprietary watch derived from public DEA and related government feeds. Not legal, DEA, FDA, or pharmaceutical advice. Fulfillment: weekly digest to the email collected at checkout. See FULFILLMENT.md for ops.